1. Home
  2. PTCT vs CSTM Comparison

PTCT vs CSTM Comparison

Compare PTCT & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$63.29

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$25.03

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
CSTM
Founded
1998
2010
Country
United States
France
Employees
991
11500
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.4B
IPO Year
2006
2012

Fundamental Metrics

Financial Performance
Metric
PTCT
CSTM
Price
$63.29
$25.03
Analyst Decision
Buy
Strong Buy
Analyst Count
17
4
Target Price
★ $80.65
$30.75
AVG Volume (30 Days)
918.2K
★ 1.3M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
264.48
★ 405.26
EPS
0.90
★ 1.42
Revenue
$264,734,000.00
★ $8,449,000,000.00
Revenue This Year
N/A
$21.46
Revenue Next Year
$17.70
$0.50
P/E Ratio
$69.20
★ $17.35
Revenue Growth
★ 36.19
15.19
52 Week Low
$58.90
$14.45
52 Week High
$90.87
$36.99

Technical Indicators

Market Signals
Indicator
PTCT
CSTM
Relative Strength Index (RSI) 34.72 38.39
Support Level N/A $22.10
Resistance Level $68.93 $27.18
Average True Range (ATR) 1.97 0.71
MACD -0.32 -0.05
Stochastic Oscillator 22.43 17.56

Price Performance

Historical Comparison
PTCT
CSTM

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About CSTM Constellium SE (France)

Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.

Share on Social Networks: